Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on LinkedIn:
“Had the opportunity to share some thoughts about the importance of biomarker testing (Oncotype Dx) in the management of breast cancer on camera with Exact Sciences during SABCS25.
Advocacy groups can empower patients to ask about biomarker testing and how to be involved in shared decisionmaking.”
More posts about Breast Cancer.
